Kameue T
Department of Anesthesiology, Asahikawa Medical College.
Masui. 1991 Mar;40(3):421-30.
The author investigated the interactions of protein binding of lidocaine by inhaled anesthetics (halothane, enflurane, isoflurane and sevoflurane in vitro and in vivo. In the in vitro study, no significant changes of protein binding ratio were observed between the controls and any concentrations of the inhaled anesthetics even under high concentration (10 MAC). However, the percent of protein binding was inversely related to the total plasma lidocaine concentration. At lidocaine concentrations of 2, 5 and 9 micrograms.ml-1, the binding ratios were 66.37 +/- 5.36 (%), 55.58 +/- 4.38(%) and 51.66 +/- 4.12(%) respectively. By regression analysis (in vivo), the following relationship was obtained. Y = -0.66X +/- 57.4 (Y: % of protein binding fraction, X: lidocaine concentration). In terms of lidocaine protein binding, there seems to be no hazard in using lidocaine with any inhaled anesthetics.
作者在体外和体内研究了吸入麻醉剂(氟烷、恩氟烷、异氟烷和七氟烷)与利多卡因的蛋白结合相互作用。在体外研究中,即使在高浓度(10MAC)下,对照组与任何浓度的吸入麻醉剂之间均未观察到蛋白结合率的显著变化。然而,蛋白结合百分比与血浆利多卡因总浓度呈负相关。当利多卡因浓度为2、5和9微克·毫升-1时,结合率分别为66.37±5.36(%)、55.58±4.38(%)和51.66±4.12(%)。通过回归分析(体内),得到以下关系:Y = -0.66X±57.4(Y:蛋白结合分数百分比,X:利多卡因浓度)。就利多卡因蛋白结合而言,将利多卡因与任何吸入麻醉剂合用似乎没有风险。